VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

Recommendations

Info

DRAFT 3 - DO NOT DISTRIBUTE VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain Appendix K: Abbreviation List Abbreviation Definition ⁰F degrees Fahrenheit 6-AM 6-acetylmorphine AAAP American Academy of Addiction Psychiatry AAPM American Academy of Pain Medicine AHRQ Agency for Healthcare Research and Quality AIDS acquired immunodeficiency syndrome AMA American Medical Association AOR adjusted odds ratio APAP acetaminophen APTA American Physical Therapy Association ARR adjusted risk ratio ASA acetylsalicylic acid ASAM American Society of Addiction Medicine BID two times per day BPI Brief Pain Inventory CARF Commission on Accreditation of Rehabilitation Facilities CBT Cognitive Behavioral Therapy CDC Centers for Disease Control and Prevention CENTRAL CI CNCP CNS COI COPD COR CPG The Cochrane Central Register of Controlled Trials 95% confidence interval chronic non-cancer pain central nervous system conflict of interest chronic obstructive pulmonary disease contracting officer's representative clinical practice guideline DATA 2000 Drug Addiction Treatment Act of 2000 DEA Drug Enforcement Administration DEA Drug Enforcement Administration dL deciliter(s) DoD Department of Defense DSM-4 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition DSM-5 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition EBPWG Evidence-Based Practice Work Group ECG electrocardiogram EDDP 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine EMR electronic medical record FDA Food and Drug Administration FY fiscal year February 2017 Page 176 of 192
DRAFT 3 - DO NOT DISTRIBUTE VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain Abbreviation GAO GCMS GI GRADE HHS HIV HMO HR hr IOM IRR KQ LCMS LOT m M3G M6G MAOI MAT mcg MDA MDEA MDMA MEDD MeSH mg MHS mL MPDATP MRI NICE NSAIDs OA OEF OEND OIF OMB OR OSI OTC Definition Government Accountability Office gas chromatography- mass spectrometry gastrointestinal Grading of Recommendations Assessment, Development and Evaluation U.S. Department of Health and Human Services human immunodeficiency virus health maintenance organization hazard ratio hour Institute of Medicine incidence rate ratios key question liquid chromatography-mass spectrometry long-term opioid therapy meter(s) morphine-3-glucuronide morphine-6-glucuronide monoamine oxidase inhibitor medication assisted treatment microgram(s) 3,4-methylenedioxy-amphetamine 3,4-methylenedioxy-N-ethyl-amphetamine 3,4-methylenedioxy-methamphetamine morphine equivalent daily dose Medical Subject Headings milligram(s) Military Health System milliliter(s) Military Personnel Drug Abuse Testing Program magnetic resonance imaging National Institute for Health and Care Excellence non-steroidal anti-inflammatory drugs osteoarthritis Operation Enduring Freedom Overdose Education and Naloxone Distribution Operation Iraqi Freedom Office of Management and Budget odds ratio Opioid Safety Initiative over the counter February 2017 Page 177 of 192
Page 1 and 2:
VA/DoD CLINICAL PRACTICE GUIDELINE
Page 3 and 4:
VA/DoD Clinical Practice Guideline
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Appendix D: Drug Tables A. Short-ac
Page 83 and 84:
Short-Acting Opioid Initial Oral Do
Page 85 and 86:
Short-Acting Opioid Initial Oral Do
Page 87 and 88:
Short-Acting Opioid Tramadol (alone
Page 89 and 90:
Long-Acting/ER Opioids 1 Buprenorph
Page 91 and 92:
Long-Acting/ER Opioids 1 Hydrocodon
Page 93 and 94:
Long-Acting/ER Opioids 1 Initial Do
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
3 CYP-3A4 inhibiting agents include
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126: VA/DoD Clinical Practice Guideline
Page 163 and 164: DRAFT 3 - DO NOT DISTRIBUTE VA/DoD
Page 175: DRAFT 3 - DO NOT DISTRIBUTE VA/DoD
show all

VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?